These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 21855113

  • 1. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions.
    Bock AJ, Nymoen DA, Brenne K, Kærn J, Davidson B.
    Hum Pathol; 2012 May; 43(5):669-74. PubMed ID: 21855113
    [Abstract] [Full Text] [Related]

  • 2. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R.
    Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
    [Abstract] [Full Text] [Related]

  • 3. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
    Davidson B, Baekelandt M, Shih IeM.
    Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
    [Abstract] [Full Text] [Related]

  • 4. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.
    Elstrand MB, Stavnes HT, Tropé CG, Davidson B.
    Hum Pathol; 2012 Apr; 43(4):529-35. PubMed ID: 21864883
    [Abstract] [Full Text] [Related]

  • 5. Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors.
    Yuan Y, Leszczynska M, Konstantinovsky S, Tropé CG, Reich R, Davidson B.
    Diagn Cytopathol; 2011 Aug; 39(8):562-6. PubMed ID: 20730893
    [Abstract] [Full Text] [Related]

  • 6. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
    Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B.
    Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
    [Abstract] [Full Text] [Related]

  • 7. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R.
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B.
    Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
    [Abstract] [Full Text] [Related]

  • 9. Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.
    Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J.
    Hum Pathol; 2011 Jul; 42(7):1019-26. PubMed ID: 21315408
    [Abstract] [Full Text] [Related]

  • 10. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.
    Yuan Y, Nymoen DA, Dong HP, Bjørang O, Shih IeM, Low PS, Trope' CG, Davidson B.
    Hum Pathol; 2009 Oct; 40(10):1453-60. PubMed ID: 19454358
    [Abstract] [Full Text] [Related]

  • 11. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma.
    Davidson B, Shih IeM, Wang TL.
    Hum Pathol; 2008 Nov; 39(11):1630-6. PubMed ID: 18656238
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities.
    Reich R, Vintman L, Nielsen S, Kaern J, Bedrossian C, Berner A, Davidson B.
    Diagn Cytopathol; 2005 Nov; 33(5):332-7. PubMed ID: 16240397
    [Abstract] [Full Text] [Related]

  • 13. Nucleoside transporters are widely expressed in ovarian carcinoma effusions.
    Bock AJ, Dong HP, Tropé CG, Staff AC, Risberg B, Davidson B.
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):467-75. PubMed ID: 21822668
    [Abstract] [Full Text] [Related]

  • 14. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
    Davidson B, Reich R, Lazarovici P, Ann Flørenes V, Nielsen S, Nesland JM.
    Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042
    [Abstract] [Full Text] [Related]

  • 15. Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases.
    Vaksman O, Davidson B, Tropé C, Reich R.
    Hum Pathol; 2013 Dec; 44(12):2677-83. PubMed ID: 24060004
    [Abstract] [Full Text] [Related]

  • 16. APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival.
    Tuft Stavnes H, Nymoen DA, Hetland Falkenthal TE, Kærn J, Tropé CG, Davidson B.
    Am J Clin Pathol; 2014 Jul; 142(1):51-7. PubMed ID: 24926085
    [Abstract] [Full Text] [Related]

  • 17. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B.
    Cancer; 2005 Apr 15; 103(8):1631-43. PubMed ID: 15742334
    [Abstract] [Full Text] [Related]

  • 18. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions.
    Davidson B, Xi Z, Klokk TI, Tropé CG, Dørum A, Scheistrøen M, Saatcioglu F.
    Am J Clin Pathol; 2005 Mar 15; 123(3):360-8. PubMed ID: 15716231
    [Abstract] [Full Text] [Related]

  • 19. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M.
    Hum Pathol; 2000 Sep 15; 31(9):1081-7. PubMed ID: 11014575
    [Abstract] [Full Text] [Related]

  • 20. Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells.
    Davidson B, Xi Z, Saatcioglu F.
    Diagn Cytopathol; 2007 Feb 15; 35(2):80-4. PubMed ID: 17230566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.